MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ25-35 -induced anxiety and cognitive deficits in a mouse model.
Hei-Jen HuangHsin-Yu HuangHsiu Mei Hsieh-LiPublished in: CNS neuroscience & therapeutics (2018)
These results reveal MGCD0103 could be a potential therapeutic agent against AD.